뉴스 Jun 02, 2023 최신 연구에 따르면 유럽 바이오테크 기업의 20%가 스위스에 본사를 두고 있습니다 Press release IQVIA가 수행하고 최근 2023 스위스 바이오테크 보고서에 발표된 새로운 연구에 따르면 유럽 바이오테크 기업의 20%가 현재 스위스에 본사를 두고 있습니다. 또한 스위스 연방 정부, 주 및 지역의 작년 투자 유치 통계에 따르면 이러한 추세가 지속되고 있음을...
Member of the Month Feb 03, 2023 BROMATECH Suisse SA: "S-GE helps us better understand sales markets as well as the distribution channels" BROMATECH Switzerland is active in the development of dietary supplements based on lactic acid bacteria capable of interacting in a targeted and ...
News Dec 07, 2020 CSL Behring opens new manufacturing facility in Bern Leading global biotech company CSL Behring has recently inaugurated a new state-of-the-art immunoglobulin manufacturing plant in the Swiss canton...
Actualités Oct 18, 2023 Le troisième bâtiment du BioArk Monthey a été inauguré Après deux décennies d’existence, le site du BioArk à Monthey continue de s’affirmer comme un acteur de premier plan dans le domaine des sciences...
Actualités Oct 18, 2023 Siegfried et Lonza en tête du classement mondial de la sous-traitance pharmaceutique Les sociétés valaisannes Lonza et Siegfried ont été reconnues parmi les principaux acteurs du paysage mondial de la sous-traitance pharmaceutique...
News Nov 16, 2020 Greater Zurich Area worthwhile for U.S. biotech companies Europe is a good market for U.S. biotech companies wishing to expand globally. The Greater Zurich Area is the perfect choice on account of its ta...
Actualités Oct 06, 2022 Le Biopôle grandit encore avec la construction de trois nouveaux bâtiments Biopôle a annoncé que la SICAV Edmond de Rothschild Real Estate investira dans la construction de trois nouveaux bâtiments sur le campus d’Epalin...
News Sep 22, 2023 TOLREMO receives 39 million US dollars in investments TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel can use this to conduc...
Actualités Oct 11, 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News Dec 12, 2023 PharmaBiome and Ferring agree cooperation PharmaBiome and the biopharmaceutical firm Ferring from the canton of Vaud will in future each jointly develop and manufacture specific bacterial...
News Jul 31, 2020 Basel gains new biotech in Bright Peak Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech...
News Sep 05, 2023 Mabylon further develops active substance to treat peanut allergy with Pfizer Biotech company Mabylon has entered into an agreement with the biotech promoter Pfizer Ignite. Mabylon plans to use this to expedite the developm...
Aktuell May 20, 2022 BeiGene eröffnet Europasitz in Basel BeiGene eröffnet in Basel seinen europäischen Hauptsitz. Die auf innovative Krebstherapien spezialisierte globale Biotechnologiefirma will von Ba...
News Feb 20, 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
スイスのテクノロジー + 産業 主要産業 各産業分野の連合組合や各セクターの運営機関が国内ネットワークのパートナーであることにより、スイス・グローバル・エンタープライズ(S-GE)はそれぞれの産業分野に合わせた国際化サービスを提供できるようになっています。同時に、連合組合やクラスターを通じて、加盟企業にS-GEのサービス内容を詳し...
Actualités Mar 08, 2022 Le site technologique de BioArk Monthey s’agrandit Suite à une première extension en 2015, le site technologique spécialisé dans les sciences de la vie, BioArk Monthey, s’agrandit à nouveau et acc...
News Jan 10, 2020 Sotio opens office in Basel The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for the company’s clinica...